The California Institute for Regenerative Medicine (CIRM) is proud to join fellow advocates of clinical trial diversity in applauding a new law that will allow the U.S. Food & Drug Administration (FDA) to require diverse representation in clinical trials. A clinical trial, as defined by the FDA, tests potential treatments in human volunteers to see … Continue reading Why diversity in clinical trials is essential
Diversity Equity and Inclusion
Stem Cell Agency Board Approves Funding for Rare Immune Disorder
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Taylor Lookofsky (center), a person with IPEX syndrome, with his father Brian and Dr. Rosa Bacchetta IPEX syndrome is a rare condition where the body can’t control or restrain an immune response, so the person’s immune cells attack their own healthy tissue. The syndrome mostly affects … Continue reading Stem Cell Agency Board Approves Funding for Rare Immune Disorder
Creating a New Model for Diversity in Scientific and Medical Research
THIS BLOG IS ALSO AVAILABLE AS AN AUDIO CAST Nature Cell Biology cover The global pandemic has highlighted many of the inequities in our health care system, and the need for more diversity in scientific and medical research. The virus hit communities of color the hardest. That has led to calls for greater diversity, equity … Continue reading Creating a New Model for Diversity in Scientific and Medical Research